Start your journey todayno insurance required
Clinical studies show an average of 15% body weight loss over 68 weeks with semaglutide, and up to 2022% with tirzepatide
Wie GLP-1-Medikamente den Blutzucker regulieren, Hunger und Sttigung beeinflussen und die Gewichtsreduktion bei Adipositas untersttzen knnen GLP-1-Rezeptor-Agonisten sind Medikamente, die die Wirkung des krpereigenen Darmhormons GLP-1 (Glucagon-like Peptide-1) nachahmen
Mounjaro Mounjaros dual agonist effect allows it to target both GLP-1 and GIP receptors
A more detailed health questionnaire covering your medical conditions, current medications, allergies, and prior weight loss attempts
This direct route is why injections offer a much higher rate of absorption, ensuring your body gets the full benefit, faster and more reliably